Dinitrophenol and obesity: An early twentieth-century regulatory dilemma

Regulatory Toxicology and Pharmacology

Volumn 48, Issue 2, 2007, Pages 115-117

  Colman, Eric ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Dinitrophenol; Food and Drug Administration; Obesity

Indexed keywords

2,4 DINITROPHENOL; DINITRO ORTHO CRESOL; FENFLURAMINE;

AGEUSIA; ARTICLE; CALORIC RESTRICTION; CARDIOTOXICITY; CATARACT; DRUG EFFICACY; DRUG FATALITY; DRUG LEGISLATION; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HISTORY OF MEDICINE; HUMAN; HYPERPYREXIA; HYPOTENSION; LIVER TOXICITY; MUSCLE DISEASE; NEURITIS; OBESITY; PARESTHESIA; PRIORITY JOURNAL; RASH; RISK BENEFIT ANALYSIS; TACHYCARDIA; VALVULAR HEART DISEASE; VISUAL IMPAIRMENT; WEIGHT REDUCTION;

EID: 34249743161     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2007.03.006     Document Type: Note

References (28)

1. Boyle, M. to Solicitor General, 1 November 1937. Accession 59A2098-B, FDA Seizure Files, The History of Medicine Division, National Library of Medicine.
2. Connolly H.M., Crary J.L., McGoon M.D., Hensrud D.D., Edwards B.S., Edwards W.D., et al. Valvular heart disease associated with fenfluramine-phentermine. N. Engl. J. Med. 337 (1997) 581-588
3. Council on Pharmacy and Chemistry, 1935. Dinitrophenol not acceptable for N.N.R. JAMA. July 6, 31-33.
4. Cutting W.C., and Tainter M.L. Actions of dinitrophenol. Proc. Soc. Exper. Biol. Med. 29 (1932) 1268-1269
5. Cutting W.C., Mehrtens H.G., and Tainter M.L. Actions and uses of dinitrophenol: promising metabolic applications. JAMA 15 (1933) 193-195
6. Dunbar, P. to Solicitor General, 6 November 1937. Accession 59A2098-B, FDA Seizure Files, The History of Medicine Division, National Library of Medicine.
7. Ernst, W. to Chief of the Chicago Station of the Food and Drug Administration, 4 February 1938. Accession 59A2098-B, FDA Seizure Files, The History of Medicine Division, National Library of Medicine.
8. Federal Food, Drug, and Cosmetic Act 1938. Pub. L. No. 717, 1040 Stat.
9. Formula 281 circular, 1934. Accession 59A2098-B, FDA Seizure Files, The History of Medicine Division, National Library of Medicine.
10. Gorov, H. to Food and Drug Administration, 12 November 1937. Accession 59A2098-B, FDA Seizure Files, The History of Medicine Division, National Library of Medicine.
11. Horner W.D. Cataract following dinitrophenol treatment for obesity. Arch. Ophth. 16 (1936) 447-461
12. Horner W.D., Jones R.B., and Boardman W.W. Cataracts following the use of dinitrophenol, preliminary report of 3 cases. JAMA 13 (1935) 108-110
13. Improved Formula 281 circular, 1935. Accession 59A2098-B, FDA Seizure Files, The History of Medicine Division, National Library of Medicine.
14. Isabella Laboratories to Food and Drug Administration, 24 February 1937. Accession 59A2098-B, FDA Seizure Files, The History of Medicine Division, National Library of Medicine.
15. Koch R.A., Lee R.C.H., and Tainter M.L. Dinitrophenol on liver function. California West M 43 (1935) 337-339
16. Loomis W.F., and Lipmann F. Reversible inhibition of the coupling between phosphorylation and oxidation. J. Biol. Chem. 173 (1948) 807-808
17. MacBryde C.M., and Taussig B.L. Functional changes in liver, heart, and muscle, and loss of dextrose tolerance resulting from dinitrophenol. JAMA 6 (1935) 13-17
18. Masserman J.H., and Goldsmith H. Dinitrophenol, its therapeutic and toxic actions in certain types of psychobiologic underactivity. JAMA 17 (1934) 523-525
19. Miranda E.J., McIntyre I.M., Parker D.R., Gary R.D., and Logan B.K. Two deaths attributed to the use of 2,4-dinitrophenol. J. Anal. Toxicol. 30 (2006) 219-222
20. Misbranding of Formula 281, September 1938. U.S. vs. Harry Gorov, USFDA, Notices of Judgment under the Food and Drugs Act.
21. Perkins R.G. A study of munitions intoxicants in France. Public Health Rep. 24 (1919) 2335-2374
22. Pure Food and Drug Act of June 30, 1906, Pub. L. No. 59-384, 34 Stat.
23. Runkel, H. to Chief Administrator of the Food and Drug Administration, 7 December 1937. Accession 59A2098-B, FDA Seizure Files, The History of Medicine Division, National Library of Medicine.
24. Strang J.M., and Evans F.A. An evaluation of dinitrophenol as an aid in weight reduction. JAMA 1 (1935) 1957-1963
25. Tainter M.L., Cutting W.C., and Stockton A.B. Use of dinitrophenol in nutritional disorders: a critical survey of clinical results. Am. J. Public Health 24 (1934) 1045-1053
26. Tainter M.L., Stockton A.B., and Cutting W.C. Dinitrophenol in the treatment of obesity, final report. JAMA 3 (1935) 332-336
27. Weight reducer causes blindness, Press Release, 22 August 1935, U.S. Department of Agriculture, Historical Health Fraud and Alternative Medicine Collection, American Medical Association Archive.
28. Weintraub M. Long-term weight control study: conclusions. Clin. Pharmacol. Ther. 51 (1992) 642-646